EFFECT OF COMBINED THERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS, INTERLEUKIN-2 AND SPECIFIC MONOCLONAL-ANTIBODY ON ESTABLISHED B-16 MELANOMA LUNG METASTASES

被引：0
|
作者：
EISENTHAL, A
CAMERON, RB
UPPENKAMP, I
ROSENBERG, SA
机构：
来源：
CANCER RESEARCH | 1988年 / 48卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7140 / 7145
页数：6
相关论文
共 50 条
  • [31] SPECIFIC BIODETECTION OF B-16 MOUSE MELANOMA INVIVO BY SYNGENEIC MONOCLONAL-ANTIBODY
    YAMASAKI, T
    WAKABAYASHI, S
    INOUE, O
    ANDO, K
    KUSAKABE, K
    KAWASAKI, Y
    OKAMOTO, S
    TANIGUCHI, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 89 (03) : 225 - 229
  • [32] CONTINUOUS INFUSION OF RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN REFRACTORY MALIGNANCIES
    CHRISTIANSEN, NP
    KENNEDY, BJ
    OCHOA, AC
    SKUBITZ, KM
    BACH, FH
    MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (06): : 455 - 458
  • [33] TREATMENT OF HEPATOCELLULAR-CARCINOMA UTILIZING LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2
    ICHIDA, T
    HIGUCHI, K
    ARAKAWA, K
    OHTA, H
    SUGIYAMA, K
    MIYAGIWA, M
    NOHZAWA, A
    SATOH, T
    SASAKI, H
    ICHIDA, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 : S45 - S48
  • [34] EFFECT OF INTERLEUKIN-2 ON FETAL THYMOCYTES IN ORGAN-CULTURES - GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELLS
    SKINNER, M
    MARBROOK, J
    CELLULAR IMMUNOLOGY, 1988, 112 (01) : 104 - 111
  • [35] THYROID FUNCTIONS IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    KUNG, AWC
    LAI, CL
    WONG, KL
    TAM, CF
    QUARTERLY JOURNAL OF MEDICINE, 1992, 82 (297): : 33 - 42
  • [36] ADOPTIVE CELLULAR THERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS PLUS INTERLEUKIN-2 (IL-2)
    LONGO, DL
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 97 - 97
  • [37] INFLUENCE OF SCHEDULE OF INTERLEUKIN-2 ADMINISTRATION ON THERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS
    THOMPSON, JA
    LEE, DJ
    LINDGREN, CG
    BENZ, LA
    COLLINS, C
    SHUMAN, WP
    LEVITT, D
    FEFER, A
    CANCER RESEARCH, 1989, 49 (01) : 235 - 240
  • [38] EFFECT OF CORTICOSTEROID ON THE ANTITUMOR-ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 IN MICE
    PAPA, MZ
    VETTO, JT
    ETTINGHAUSEN, SE
    MULE, JJ
    ROSENBERG, SA
    CANCER RESEARCH, 1986, 46 (11) : 5618 - 5623
  • [39] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY - ANALYSIS OF A BOLUS INTERLEUKIN-2 AND A CONTINUOUS INFUSION INTERLEUKIN-2 REGIMEN
    CLARK, JW
    SMITH, JW
    STEIS, RG
    URBA, WJ
    CRUM, E
    MILLER, R
    MCKNIGHT, J
    BEMAN, JA
    STEVENSON, HC
    CREEKMORE, S
    STEWART, M
    CONLON, K
    SZNOL, M
    KREMERS, P
    COHEN, P
    LONGO, DL
    CANCER RESEARCH, 1990, 50 (22) : 7343 - 7350
  • [40] A PHASE-II STUDY OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    DUTCHER, JP
    CREEKMORE, S
    WEISS, GR
    MARGOLIN, K
    MARKOWITZ, AB
    ROPER, M
    PARKINSON, D
    CIOBANU, N
    FISHER, RI
    BOLDT, DH
    DOROSHOW, JH
    RAYNER, AA
    HAWKINS, M
    ATKINS, M
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 477 - 485
12345